In contrast, luteolin has the highest binding affinity to EGFR, inhibits EGFR autophosphorylation, and promotes EGFR degradation via the lysosomal pathway in epidermoid carcinoma (A431) and NSCLC (NCI-H1975) cells. Here, EGFR is linked to non-small cell lung carcinoma.